c22 Galactosylceramide (d18:1/22:0)

CAS : 74645-25-3

Ref. 3D-ZCA64525

Informations sur le produit

• Nom: c22 Galactosylceramide (d18:1/22:0)
• Marque: Biosynth
• Description: C22 Galactosylceramide (d18:1/22:0) is a potent analog of the naturally occurring glycosphingolipid ceramide. It has been shown to inhibit kinases involved in cancer cell growth and survival, making it a promising anticancer agent. In Chinese hamster ovary cells, C22 Galactosylceramide induces apoptosis and inhibits tumor growth. Additionally, this compound has been found to be a medicinal inhibitor of protein kinase C (PKC), which is involved in many cellular processes such as cell proliferation and differentiation. C22 Galactosylceramide has also been detected in human urine, suggesting that it may have potential as a biomarker for certain diseases. Overall, this compound shows great promise as a therapeutic agent for cancer treatment.

Propriétés chimiques

• Masse moléculaire: 784.2 g/mol
• Formule: C₄₆H₈₉NO₈
• Degré de pureté: Min. 95%